Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 1;11:38. doi: 10.3389/fnana.2017.00038

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 Sherry, Hopiavuori, Stiles, Rahman, Ozan, Deak, Agbaga and Anderson.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Expression of ELOVL4 in the hypothalamus and midbrain. (A) Extensive ELOVL4 labeling is present in the hypothalamus (HY). Prominent labeling is seen in the lateral preoptic area (LPO), lateral mammilary nucleus (LM), zona incerta (ZI), and in parts of the lateral hypothalamic area (LHA). TH, Thalamus; opt, optic tract. (B) Labeling for ELOVL4 in the midbrain is widespread but varies among nuclei. Prominent labeling is present in the superior colliculus (SC), inferior colliculus (IC), midbrain reticular nucleus (MRN), and anterior pretectal nucleus (APN). Substantia nigra (SN) shows much less labeling for ELOVL4 than other portions of the midbrain. Cerebellum (CB), cortex (CTX), and zona incerta (ZI) also are visible. Scale bars = 500 μm.